Risk assessment in pulmonary arterial hypertension treated with prostacyclins: a retrospective analysis

被引：0
|
作者：
Dendievel, Renaud [1 ]
Vachiery, Jean-Luc [1 ]
Dewachter, Celine [1 ]
机构：
[1] Hop Erasme, Brussels, Belgium
来源：
ACTA CARDIOLOGICA | 2020年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [21] Pulmonary Arterial Hypertension risk assessment model using Bayesian Network analysis
    Fauvel, C.
    Liu, Z.
    Lin, S.
    Correa-Jaque, P.
    Webb, A.
    Vanderpool, R.
    Benza, R.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [22] Medical therapy of pulmonary hypertension -: The prostacyclins
    Galié, N
    Manes, A
    Branzi, A
    CLINICS IN CHEST MEDICINE, 2001, 22 (03) : 529 - +
  • [23] New Tricks for an Old Drug: Prostacyclins and Right Ventricular Contractility in Pulmonary Arterial Hypertension
    Wertheim, Bradley M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (01) : 12 - 13
  • [24] COMMON VARIABLE IMMUNODEFICIENCY WITH GROUP 1 PULMONARY HYPERTENSION TREATED WITH INHALED PROSTACYCLINS
    Sharma, Rajaninder
    Ismail, Reem
    Abu Sayf, Alaa
    Hegab, Sara
    CHEST, 2021, 160 (04) : 2191A - 2191A
  • [25] Effect of Obesity on Mortality in Pulmonary Arterial Hypertension: A Retrospective Analysis
    Badri, M.
    Saeed, W.
    Lahoti, A.
    Salamon, J.
    Gnall, E.
    Sardar, M. R.
    Zolty, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S283 - S283
  • [26] Hypoalbuminemia Is a Predictor of Mortality in Pulmonary Arterial Hypertension: A Retrospective Analysis
    Sardar, M. R.
    Saeed, W.
    Rab, Z.
    Salamon, J. N.
    Zolty, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S107 - S108
  • [27] EFFECT OF OBESITY ON MORTALITY IN PULMONARY ARTERIAL HYPERTENSION: A RETROSPECTIVE ANALYSIS
    Badri, Marwan
    Saeed, Wajeeha
    Lahoti, Ankush
    Salamon, Jason
    Gnall, Eric
    Zolty, Ronald
    Sardar, Rizwan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1590 - E1590
  • [28] A Retrospective Analysis of Adherence to Risk Evaluation and Mitigation Strategies Requirements for Pulmonary Arterial Hypertension Drugs
    Prokes, Mackenzie
    Root, Adam
    HOSPITAL PHARMACY, 2019, 54 (05) : 309 - 313
  • [29] Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension
    Caroline O’Connell
    David Amar
    Athénaïs Boucly
    Laurent Savale
    Xavier Jaïs
    Marie-Camille Chaumais
    David Montani
    Marc Humbert
    Gérald Simonneau
    Olivier Sitbon
    Drug Safety, 2016, 39 : 287 - 294
  • [30] Risk assessment in Scleroderma-associated pulmonary arterial hypertension
    Mercurio, Valentina
    Diab, Nermin
    Peloquin, Grace
    Housten-Harris, Traci
    Damico, Rachel
    Kolb, Todd M.
    Mathai, Stephen C.
    Hassoun, Paul M.
    VASCULAR PHARMACOLOGY, 2020, 132
12345